StockNews.com Upgrades Aspen Aerogels (NYSE:ASPN) to Sell

Aspen Aerogels (NYSE:ASPN) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a note issued to investors on Wednesday.

Other equities research analysts have also issued reports about the stock. Benchmark reaffirmed a “buy” rating and issued a $14.00 price objective on shares of Aspen Aerogels in a research note on Thursday, August 8th. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Roth Mkm cut their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday. Finally, TD Cowen increased their price target on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $15.12 on Wednesday. The firm has a market cap of $1.24 billion, a price-to-earnings ratio of 1,553.55 and a beta of 2.21. Aspen Aerogels has a 1 year low of $9.89 and a 1 year high of $33.15. The stock’s 50-day moving average is $22.44 and its two-hundred day moving average is $24.67. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.82 and a current ratio of 2.93.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Institutional Investors Weigh In On Aspen Aerogels

Hedge funds and other institutional investors have recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Aspen Aerogels by 10.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock worth $341,000 after purchasing an additional 1,339 shares in the last quarter. nVerses Capital LLC boosted its holdings in shares of Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after purchasing an additional 1,800 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Aspen Aerogels by 15.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock valued at $257,000 after buying an additional 1,938 shares in the last quarter. Point72 Hong Kong Ltd acquired a new position in Aspen Aerogels in the 2nd quarter valued at approximately $84,000. Finally, Quent Capital LLC bought a new position in Aspen Aerogels during the 3rd quarter worth $118,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.